Tenacibaculum maritimum (Marine Flexibacteriosis)

Tenacibaculum maritimum causes marine flexibacteriosis, also called tenacibaculosis, across a broad range of farmed marine finfish species, with salmon, several flatfish species, and various other marine finfish all documented as susceptible hosts, producing characteristic skin ulceration, fin erosion, and mouth lesions that in severe cases can expose underlying tissue and create secondary infection vulnerability, a progressive external tissue damage pattern that distinguishes this pathogen's clinical presentation from the more internal, systemic septicemic presentation characteristic of several other significant bacterial fish pathogens discussed throughout this glossary. The disease shows documented association with handling stress, net and equipment abrasion creating skin damage that facilitates bacterial entry, and sea lice attachment wounds specifically, meaning tenacibaculosis frequently presents as a secondary or opportunistic infection complicating an underlying physical injury or parasite attachment site rather than necessarily representing a primary, independently initiated infection in otherwise undamaged skin, a pattern that connects this pathogen's management directly to the broader sea lice and handling-stress management content discussed elsewhere in this glossary, since effective control of those underlying predisposing factors reduces tenacibaculosis risk even without any pathogen-specific intervention. Treatment options include antibiotic therapy for confirmed, clinically significant cases, though as with several other bacterial pathogens discussed in this cluster, antibiotic susceptibility testing of the specific isolated strain is recommended practice before treatment selection given documented resistance variation across different regional bacterial populations, and some management approaches emphasize bath or external treatment approaches given the pathogen's predominantly external, skin-surface-associated disease mechanism rather than relying solely on systemic in-feed antibiotic delivery better suited to purely internal infections. Vaccine development against Tenacibaculum maritimum has faced documented challenges related to the pathogen's genetic diversity across different circulating strains, with vaccine efficacy sometimes limited against strains genetically distant from whatever strain the vaccine was originally developed and validated against, a strain-mismatch challenge similar in underlying logic to the strain-coverage considerations discussed elsewhere in this glossary's multivalent vaccine entry.